C12Y 204/01008
Maltose phosphorylase
Official title: Maltose phosphorylase (2.4.1.8)
C12Y204/01008 (Maltose phosphorylase) appears on 8 US grants and 10 published applications in this corpus.
Search patents in C12Y- Granted patents
- 8
- Published applications
- 10
- Assignees
- 3
- Inventors
- 5
- Latest grant
- 24 Sep 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 2 |
| 2020 | 2 | 2 |
| 2021 | 3 | 2 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Metabolically engineered organisms for the production of added value bio-products24 Sep 2024US 12,098,403 B2Inbiose N.V.
- Metabolically engineered organisms for the production of added value bio-products12 Jul 2022US 11,384,374 B2Inbiose N.V.
- Enzymatic production of D-allulose9 Nov 2021US 11,168,342 B2Bonumose, Inc.
- Enzymatic production of D-allulose3 Aug 2021US 11,078,506 B2Bonumose, Inc.
- Enzymatic production of D-allulose6 Jul 2021US 11,053,528 B2Bonumose, Inc.
- Metabolically engineered organisms for the production of added value bio-products13 Feb 2025US 2025/0051813 A1Inbiose N.V.
- Enzymatic production of d-allulose31 Mar 2022US 2022/0098632 A1Bonumose, Inc.
- Enzymatic production of d-allulose15 Apr 2021US 2021/0108241 A1Bonumose, Inc.
- Metabolically engineered organisms for the production of added value bio-products21 Jan 2021US 2021/0017558 A1Inbiose N.V.
- Enzymatic production of d-allulose2 Jul 2020US 2020/0208187 A1Bonumose, Inc.
Most cited
By later US patents
- Enzymatic production of D-allulose2US 11,053,528 B2Bonumose, Inc. · 2021
- Metabolically engineered organisms for the production of added value bio-products2US 9,701,992 B2Universiteit Gent · 2017
- Enzymatic production of D-allulose1US 10,704,069 B2Bonumose, Inc. · 2020
- Enzymatic production of D-allulose1US 11,078,506 B2Bonumose, Inc. · 2021
- Enzymatic production of D-allulose1US 11,168,342 B2Bonumose, Inc. · 2021